Related Experiment Video
Updated: Jun 7, 2025
07:04
Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
Published on: February 11, 2017
19.2K
Exploring Therapeutic Strategies for Pediatric Cystic Fibrosis: An In-Depth Comparative Review.
Alisha Lakhani1,2, Ruchira Clementina3, Zainab Siddiqua4
1Research, Research MD, Vadodara, IND.
Cureus
|November 20, 2024
Summary
This review compares cystic fibrosis (CF) treatments for children, evaluating medications, airway clearance, nutrition, and new therapies like gene therapy. It emphasizes personalized care plans to improve outcomes for pediatric CF patients.
Area of Science:
- Pediatric Pulmonology
- Genetic Disorders
- Medical Therapeutics
Background:
- Cystic Fibrosis (CF) is a genetic disorder impacting pediatric respiratory and digestive systems.
- Effective management of CF in children requires a multifaceted approach.
- Current treatment landscape necessitates comparative analysis for optimized care.
Purpose of the Study:
- To comparatively analyze diverse treatment modalities for pediatric cystic fibrosis.
- To evaluate the efficacy, safety, and accessibility of current and emerging CF therapies.
- To identify factors influencing treatment outcomes in pediatric CF patients.
Main Methods:
- Systematic literature review of pharmacological interventions, airway clearance techniques, and nutritional management.
- Comparative analysis of CF transmembrane conductance regulator (CFTR) modulators versus traditional treatments.
- Inclusion of emerging therapies such as gene therapy and personalized medicine.
Main Results:
- Efficacy and safety profiles of various CF treatments were compared across diverse pediatric populations.
- Airway clearance techniques' effectiveness was linked to lung function outcomes.
- Socioeconomic factors and healthcare systems influence treatment adherence and outcomes.
Conclusions:
- Individualized care plans are crucial for optimizing pediatric CF patient outcomes.
- Comparative analysis provides a foundation for refining therapeutic strategies.
- Further research into emerging therapies and personalized medicine is warranted.
More Related Videos
Related Concept Videos
01:24Cystic Fibrosis: Management
142
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
142
01:23Cystic Fibrosis: Pathogenesis
192
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
192
01:29Chronic Pancreatitis II: Collaborative Care
70
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
70
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:29Acute Respiratory Failure-V
123
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
123